Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
Pandemics and Biosecurity
3OCT

A second Ebola centre walks out on pay

2 min read
13:42UTC

Staff at the Elikya Ebola Treatment Centre struck over unpaid wages on 25 July. Elikya is not Rwampara: this is the second centre lost to payroll failure in twelve days.

ScienceDeveloping
Key takeaway

Two Ebola centres in twelve days have lost staff to unpaid wages, not to the virus.

Staff at the Elikya Ebola Treatment Centre in Ituri walked out over unpaid wages on Saturday 25 July⁠1. Elikya is a different facility from Rwampara, where workers abandoned an isolation ward on 13 July after a province-wide stoppage over unclaimed hazard pay four days before that. Readers WHO remember last week's dispute are not reading about it again: two treatment centres have now lost their staff to the same cause, twelve days apart.

Rwampara alone could be settled locally, as a grievance against one payroll office. A second walkout at a second site, over the same unpaid wages, describes a financing pipeline that is not reaching the people WHO put on the suits. The Pandemic Fund activated up to $220.6m in emergency grant financing for this response on 5 June, part of an aggregate funding figure that passed $990m the following week. Money committed in Washington and Geneva has to travel through a national treasury, a provincial health division and a payroll list before it becomes a nurse's wage in Bunia, and each of those steps has stalled somewhere.

An Ebola treatment centre without staff does not degrade gracefully. Doffing an isolation suit safely takes two trained people, decontamination runs on a schedule, and a ward that loses its nurses stops admitting rather than admitting badly. Every hour Elikya's staff were away is capacity subtracted from a province already turning patients toward wards they cannot easily reach. Donors can announce further tranches; the constraint sits between the announcement and the payslip.

Deep Analysis

In plain English

Health workers at the Elikya Ebola Treatment Centre stopped showing up for work because they had not been paid. This is not the first time this has happened. Twelve days earlier, staff at a different treatment centre, Rwampara, did the same thing over the same issue. International donors have committed significant money to fund this response, but that money has to travel through several administrative steps before it reaches an individual nurse or cleaner's pocket, and something along that chain keeps breaking down. Every day a treatment centre runs short-staffed because of unpaid wages is a day patients inside it get less care.

Deep Analysis
Root Causes

Elikya is the second treatment centre to lose staff to a payroll dispute in under two weeks, following Rwampara on 13 July, which indicates a systemic failure in wage disbursement rather than an isolated grievance at one facility. The root structural condition is a payment chain with too many intermediary steps between the Pandemic Fund's activated financing and an individual worker's bank account or cash payment, each step a possible point of delay.

A second structural cause is the absence, until officials' post-Rwampara pledge to digitise the system, of a verified personnel list; without one, disbursing agencies cannot confirm WHO is owed what, which slows payment even when funds are available.

Escalation

Direction: worsening. Elikya is a distinct centre from Rwampara, meaning the payroll collapse is spreading to a second facility rather than a single dispute continuing, and no evidence yet shows the digitised payment system officials pledged after Rwampara has been implemented.

What could happen next?
  • Consequence

    A second treatment centre losing staff to unpaid wages reduces the response's total functioning bed and care capacity independent of the case count itself.

  • Risk

    If the payment chain that failed Rwampara and Elikya is not fixed, further treatment centres in Ituri face the same walkout risk.

First Reported In

Update #12 · Two-thirds of Ebola deaths never reach a ward

Health Policy Watch· 31 Jul 2026
Read original →
Causes and effects
This Event
A second Ebola centre walks out on pay
The payroll collapse in Ituri's Ebola response is spreading from one treatment centre to another, in a response that has hundreds of millions of dollars notionally behind it.
Different Perspectives
IGWG co-chair Tovar da Silva Nunes
IGWG co-chair Tovar da Silva Nunes
The Brazilian co-chair closed the eighth pathogen-sharing session on 18 September without an agreed annex text, the second session in a row to end that way. He presented the outcome as continued commitment, with adoption due at the World Health Assembly in May 2027.
Fraport
Fraport
The Frankfurt Airport operator has told staff to watch for fever, hessenschau reported, after six airport workers caught malaria. Germany does not require insecticide spraying of arriving aircraft cabins, and parasite genotyping to trace the source is due at the end of October.
European Centre for Disease Prevention and Control
European Centre for Disease Prevention and Control
ECDC reported the eight Frankfurt Airport malaria cases on 18 September and considers repeated arrivals of infected mosquitoes on aircraft likely. It has not ruled out local mosquitoes, and awaits genotyping due at the end of October.
Pan American Health Organization
Pan American Health Organization
PAHO counted 53,957 measles cases in the Americas by 19 September and is supporting Peru's response in Puno and Arequipa. It warns that October's Señor de los Milagros festivities and Pope Leo XIV's November visit could increase transmission.
Bangladesh Directorate General of Health Services
Bangladesh Directorate General of Health Services
The DGHS recorded 1,030 measles-related deaths and 172,720 suspected cases by 14 September, after a campaign that reached 19.75 million children. Its disease-control director, Halimur Rashid, said further vaccination rounds were expected within two weeks.
Minapharm
Minapharm
The Egyptian drugmaker and its Berlin subsidiary ProBioGen were awarded up to US$16.5m by CEPI on 27 August to take a Bundibugyo vaccine into a Phase 1 trial in Africa. Final manufacture is planned for Cairo, making it CEPI's first Bundibugyo candidate with an African producer.